G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| U3KPZ7 | RNA-binding protein 27 | ||
| V6CIU7 | choline-phosphate cytidylyltransferase | ||
| V6CKC3 | C2H2-type domain-containing protein | ||
| V9GYH0 | Homeobox domain-containing protein (Fragment) |
| Pathway Name | Organism |
|---|---|
| E.coli O4-H5 | Escherichia coli |
| E.coli O4-K52 | Escherichia coli |
| E.coli O40 | Escherichia coli |
| E.coli O41 | Escherichia coli |
| E.coli O42 | Escherichia coli |
| E.coli O45rel | Escherichia coli |
| E.coli O48 | Escherichia coli |
| E.coli O53 | Escherichia coli |
| E.coli O55 | Escherichia coli |
| E.coli O56 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 35253970 | Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance | Walter JD | 2022 Mar 07 |
|
| 35256819 | An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy | Chan S | 2022 Mar 07 |
|
| 35253643 | How clustered protocadherin binding specificity is tuned for neuronal self-/nonself-recognition | Goodman KM | 2022 Mar 07 |
|
| 35133176 | Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody | Yin W | 2022 Mar 04 |
|
| 35246509 | Evolution of the SARS-CoV-2 spike protein in the human host | Wrobel AG | 2022 Mar 04 |
|
| 35241675 | Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain | Ye G | 2022 Mar 03 |
|
| 35120603 | Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron | Cui Z | 2022 Mar 03 |
|
| 35236939 | Structural basis of the activation of metabotropic glutamate receptor 3 | Fang W | 2022 Mar 02 |
|
| 35230102 | Thermal Proteome Profiling Reveals the O-GlcNAc-Dependent Meltome | King DT | 2022 Mar 01 |
|
| 35172173 | Cryo-EM structure of the SARS-CoV-2 Omicron spike | Cerutti G | 2022 Mar 01 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025